We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$463M
AUM Growth
+$88.4M
Cap. Flow
+$76.3M
Cap. Flow %
16.48%
Top 10 Hldgs %
15.82%
Holding
310
New
106
Increased
69
Reduced
87
Closed
41

Top Buys

Rank Stock Value
1
PFPT
Proofpoint, Inc.
PFPT
+$5.74M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.51M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.03M
4
IMPV
Imperva, Inc.
IMPV
+$4.56M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$2.3M

Top Sells

Rank Stock Value
1
TEN
Tenneco Inc. Class A Voting Common Stock
TEN
+$4.9M
2
TSCO icon
Tractor Supply
TSCO
+$4.44M
3
LPNT
LifePoint Health, Inc.
LPNT
+$3.96M
4
WCC
WESCO International
WCC
+$3.55M
5
IDTI
Integrated Device Technology I
IDTI
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Technology 14.58%
3 Industrials 10.71%
4 Consumer Staples 7.92%
5 Materials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
101
Walt Disney
DIS
$165B
$1M 0.22%
9,304
-5,313
-36% -$547K
LUV icon
102
Southwest Airlines
LUV
$22B
$990K 0.21%
+15,123
New +$889K
CELG
103
DELISTED
Celgene Corp
CELG
$984K 0.21%
+9,430
New +$1.06M
CMCSA icon
104
Comcast
CMCSA
$79.7B
$982K 0.21%
24,518
-310
-1% -$11.7K
GD icon
105
General Dynamics
GD
$105B
$972K 0.21%
+4,776
New +$976K
NOC icon
106
Northrop Grumman
NOC
$77B
$972K 0.21%
+3,169
New +$952K
RTN
107
DELISTED
Raytheon Company
RTN
$971K 0.21%
5,168
+242
+5% +$45.1K
TMHC icon
108
Taylor Morrison
TMHC
$6.67B
$936K 0.2%
+38,237
New +$895K
SHY icon
109
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$911K 0.2%
10,860
+234
+2% +$19.7K
ZIXI
110
DELISTED
Zix Corporation
ZIXI
$908K 0.2%
207,202
-135,851
-40% -$640K
RGA icon
111
Reinsurance Group of America
RGA
$15.7B
$907K 0.2%
5,814
-249
-4% -$37.7K
VRNS icon
112
Varonis Systems
VRNS
$5.25B
$902K 0.19%
+55,755
New +$875K
LLL
113
DELISTED
L3 Technologies, Inc.
LLL
$898K 0.19%
4,539
+25
+0.6% +$4.76K
CLX icon
114
Clorox
CLX
$11.6B
$886K 0.19%
+5,958
New +$811K
LOW icon
115
Lowe's Companies
LOW
$116B
$860K 0.19%
9,254
-98
-1% -$8.1K
DD icon
116
DuPont de Nemours
DD
$18.6B
$855K 0.18%
4,741
-101
-2% -$18.2K
ORCL icon
117
Oracle
ORCL
$331B
$851K 0.18%
17,989
+5
+0% +$245
SBUX icon
118
Starbucks
SBUX
$118B
$847K 0.18%
+14,754
New +$835K
ESNT icon
119
Essent Group
ESNT
$6.06B
$833K 0.18%
19,189
-38
-0.2% -$1.66K
WY icon
120
Weyerhaeuser
WY
$17.3B
$825K 0.18%
23,397
+2,636
+13% +$93.3K
CB icon
121
Chubb
CB
$140B
$805K 0.17%
5,512
-199
-3% -$29.7K
MAS icon
122
Masco
MAS
$16B
$799K 0.17%
18,186
+300
+2% +$12.2K
HF
123
DELISTED
HFF Inc.
HF
$790K 0.17%
16,233
-660
-4% -$29.1K
LDOS icon
124
Leidos
LDOS
$14.1B
$788K 0.17%
+12,210
New +$765K
UPS icon
125
United Parcel Service
UPS
$97.6B
$788K 0.17%
6,612
-442
-6% -$51.9K
3 4
5
6 7

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2017 Portfolio in Review

As of Q4 2017, Stanley-Laman Group held 310 positions worth $463M, up 24% from $375M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group deployed $76.3M of net new capital in Q4 2017, opening 106 new positions and adding to 69 existing holdings. Its largest new stake was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was JBT Marel, an estimated $889K trimmed.

  • Stanley-Laman Group's largest Q4 2017 buy was La Jolla Pharmaceutical Company: 168,653 shares worth $5.43M.
  • Stanley-Laman Group added most to Proofpoint, Inc. in Q4 2017, an estimated $5.74M increase.
  • Stanley-Laman Group's biggest Q4 2017 reduction was JBT Marel, cutting an estimated $889K.
  • Stanley-Laman Group fully exited Tenneco Inc. Class A Voting Common Stock in Q4 2017, selling an estimated $4.9M.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $463M portfolio in Q4 2017.
  • Stanley-Laman Group opened 106 new positions and closed 41 in Q4 2017.
  • Stanley-Laman Group's portfolio value rose 24% quarter-over-quarter to $463M.

Based on Stanley-Laman Group's 13F filing for Q4 2017, filed 9 Feb 2018.